Amgen names CEO Robert Bradway to board
THOUSAND OAKS, Calif. (AP) — Biotechnology company Amgen Inc. said Thursday that it named President and CEO Robert Bradway as a board member.
Bradway, 48, began working at Amgen as its operations strategy vice president and was chief financial officer from April 2007 to May 2010.
With Bradway as a director, Amgen's board now has 13 directors.
Also Thursday, Amgen's board declared a regular quarterly dividend of 28 cents. The dividend is payable Dec. 8 to shareholders of record as of Nov. 17.